These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37236162)

  • 1. Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report.
    Lee TD; Aisner DL; David MP; Eno CC; Gagan J; Gocke CD; Guseva NV; Haley L; Jajosky AN; Jones D; Mansukhani MM; Mroz P; Murray SS; Newsom KJ; Paulson V; Roy S; Rushton C; Segal JP; Senaratne TN; Siddon AJ; Starostik P; Van Ziffle JAG; Wu D; Xian RR; Yohe S; Kim AS
    Blood Adv; 2023 Aug; 7(16):4599-4607. PubMed ID: 37236162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing-based panel testing for myeloid neoplasms.
    Kuo FC; Dong F
    Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
    Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
    Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies.
    Zhang BM; Keegan A; Li P; Lindeman NI; Nagarajan R; Routbort MJ; Vasalos P; Kim AS; Merker JD
    Arch Pathol Lab Med; 2021 Sep; 145(9):1110-1116. PubMed ID: 33450747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proficiency testing for bacterial whole genome sequencing: an end-user survey of current capabilities, requirements and priorities.
    Moran-Gilad J; Sintchenko V; Pedersen SK; Wolfgang WJ; Pettengill J; Strain E; Hendriksen RS;
    BMC Infect Dis; 2015 Apr; 15():174. PubMed ID: 25887164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
    Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
    Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interpretation of Sequence Variants in Myeloid Neoplasms.
    Hanbazazh M; Harada S; Reddy V; Mackinnon AC; Harbi D; Morlote D
    Am J Clin Pathol; 2021 Oct; 156(5):728-748. PubMed ID: 34155503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of next-generation sequencing in hematologic malignancies.
    Ramkissoon LA; Montgomery ND
    Hum Immunol; 2021 Nov; 82(11):859-870. PubMed ID: 33648805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
    Kuo FC
    Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing in hematolymphoid neoplasia.
    Kuo FC
    Semin Hematol; 2019 Jan; 56(1):2-6. PubMed ID: 30573040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.
    Kluk MJ; Lindsley RC; Aster JC; Lindeman NI; Szeto D; Hall D; Kuo FC
    J Mol Diagn; 2016 Jul; 18(4):507-15. PubMed ID: 27339098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of next generation sequencing results on clinical management in patients with hematological disorders.
    Patel BJ; Barot SV; Xie Y; Cook JR; Carraway HE; Hsi ED
    Leuk Lymphoma; 2021 Jul; 62(7):1702-1710. PubMed ID: 33533694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
    Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
    Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genomics Organization for Academic Laboratories (GOAL): A vision for a genomics future for academic pathology.
    Aisner DL; Gocke CD; Jones D; Limson M; Morrissette J; Segal JP
    Acad Pathol; 2023; 10(3):100090. PubMed ID: 37583476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.
    Kim H; Yun JW; Lee ST; Kim HJ; Kim SH; Kim JW;
    Ann Lab Med; 2019 Nov; 39(6):515-523. PubMed ID: 31240878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts and future directions for hemato-oncologic diagnostics.
    Flach J; Shumilov E; Joncourt R; Porret N; Novak U; Pabst T; Bacher U
    Crit Rev Oncol Hematol; 2020 Jul; 151():102977. PubMed ID: 32446181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.
    Northrup V; Maybank A; Carson N; Rahmeh T
    Am J Clin Pathol; 2020 Apr; 153(5):639-645. PubMed ID: 31875888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic testing in myeloid malignancy.
    Docking TR; Karsan A
    Int J Lab Hematol; 2019 May; 41 Suppl 1():117-125. PubMed ID: 31069982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
    Aguilera-Diaz A; Vazquez I; Ariceta B; Mañú A; Blasco-Iturri Z; Palomino-Echeverría S; Larrayoz MJ; García-Sanz R; Prieto-Conde MI; Del Carmen Chillón M; Alfonso-Pierola A; Prosper F; Fernandez-Mercado M; Calasanz MJ
    PLoS One; 2020; 15(1):e0227986. PubMed ID: 31978184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.